title: Mortality risk factors of Acinetobacter baumannii bacteraemia.
abstract: BACKGROUND
  Acinetobacter baumannii is one of the most important nosocomial pathogens, and its multiple antibiotic resistance has emerged as an obstacle in the treatment of these infections worldwide.
  
  
  OBJECTIVE
  To identify risk factors of mortality for A. baumannii bacteraemia.
  
  
  METHODS
  A retrospective cohort study of 72 patients with significant A. baumannii bacteraemia was conducted to evaluate risk factors for mortality.
  
  
  RESULTS
  The median age of the 72 enrolled patients was 48 years, 96% of the cases were hospital-acquired, and the bacteraemia-related mortality rate was 29% (21 of 72 patients). Univariate analysis revealed that the risk factors for mortality included: an elevated acute physiology and chronic health evaluation (APACHE II) score, receipt of in vitro ineffective definitive antimicrobial therapy, in vitro A. baumannii resistance to cefoperazone/ sulbactam, neutropenia, and presentation with septic shock. Multivariate analysis reveals that the independent risk factors for mortality are neutropenia and elevated APACHE II scores.
  
  
  CONCLUSIONS
  Risk factors such as neutropenia and elevated APACHE II scores are found to be associated with higher mortality rates of A. baumannii bacteraemia. Further study is necessary for the determination of optimal strategies for both the prevention and treatment of these infections.
authors.affiliation: Department of Internal Medicine and AIDS Research Institute, Yonsei University College of Medicine, Seodaemun-gu, Seoul, Korea.
authors.forename: J Y
authors.initials: JY
authors.lastname: Choi
authors.forename: Y S
authors.initials: YS
authors.lastname: Park
authors.forename: C O
authors.initials: CO
authors.lastname: Kim
authors.forename: Y S
authors.initials: YS
authors.lastname: Park
authors.forename: H J
authors.initials: HJ
authors.lastname: Yoon
authors.forename: S Y
authors.initials: SY
authors.lastname: Shin
authors.forename: Y-A
authors.initials: YA
authors.lastname: Kim
authors.forename: Y G
authors.initials: YG
authors.lastname: Song
authors.forename: D
authors.initials: D
authors.lastname: Yong
authors.forename: K
authors.initials: K
authors.lastname: Lee
authors.forename: J M
authors.initials: JM
authors.lastname: Kim
mesh_terms: D000151:Acinetobacter Infections / Q000188:drug therapy / Q000382:microbiology / Q000401:mortality*; D040981:Acinetobacter baumannii / Q000302:isolation & purification*; D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D016470:Bacteremia / Q000188:drug therapy / Q000382:microbiology / Q000401:mortality*; D002648:Child; D002675:Child, Preschool; D015331:Cohort Studies; D024881:Drug Resistance, Bacterial; D005260:Female; D006801:Humans; D007223:Infant; D007723:Korea / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D012307:Risk Factors; D015996:Survival Rate